BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Schiefke I, Fach A, Wiedmann M, Aretin AV, Schenker E, Borte G, Wiese M, Moessner J. Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 2005; 11(12): 1843-1847 [PMID: 15793878 DOI: 10.3748/wjg.v11.i12.1843]
URL: https://www.wjgnet.com/1007-9327/full/v11/i12/1843.htm
Number Citing Articles
1
G. GERSTNER, M. L. DAMIANO, A. TOM, C. WORMAN, W. SCHULTZ, M. RECHT, A. T. STOPECK. Prevalence and risk factors associated with decreased bone mineral density in patients with haemophiliaHaemophilia 2009; 15(2): 559 doi: 10.1111/j.1365-2516.2008.01963.x
2
Michael T. Yin, Michelle A. Kendall, Xingye Wu, Katherine Tassiopoulos, Marc Hochberg, Jeannie S. Huang, Marshall J. Glesby, Hector Bolivar, Grace A. McComsey. Fractures after antiretroviral initiationAIDS 2012; 26(17): 2175 doi: 10.1097/QAD.0b013e328359a8ca
3
Sangheun Lee, Jun Yong Park, Kijun Song, Do Young Kim, Beom Kyung Kim, Seung Up Kim, Hye Jin Ku, Kwang-Hyub Han, Sang Hoon Ahn. Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis BGut and Liver 2015; 9(6): 776 doi: 10.5009/gnl14297
4
Germán López-Larramona, Alfredo J Lucendo, Sonia González-Castillo, José M Tenias. Hepatic osteodystrophy: An important matter for consideration in chronic liver diseaseWorld Journal of Hepatology 2011; 3(12): 300-307 doi: 10.4254/wjh.v3.i12.300
5
Eric Bonnet, Jean-Bernard Ruidavets, Anne Genoux, Laurence Mabile, Florian Busato, Martine Obadia, François Prévoteau, Bruno Marchou, Patrice Massip, Fabrice Marion-Latard, Cyrille Delpierre, Jacques Bernard, Bertrand Perret. Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: the prospective Lipotrip studyBMC Infectious Diseases 2013; 13(1) doi: 10.1186/1471-2334-13-293
6
Jennifer C. Lai, Dolores M. Shoback, Jacob Zipperstein, Blanca Lizaola, Samuel Tseng, Norah A. Terrault. Bone Mineral Density, Bone Turnover, and Systemic Inflammation in Non-cirrhotics with Chronic Hepatitis CDigestive Diseases and Sciences 2015; 60(6): 1813 doi: 10.1007/s10620-014-3507-6
7
Mohammadreza Bordbar, Sara Olyaeinezhad, Forough Saki, Sezaneh Haghpanah. Prevalence of Low Bone Mass in Patients with Hemophilia and Its Related Ractors in Southern IranJournal of Comprehensive Pediatrics 2020; 11(4) doi: 10.5812/compreped.97291
8
Bruce A. Luxon. Bone Disorders in Chronic Liver DiseasesCurrent Gastroenterology Reports 2011; 13(1): 40 doi: 10.1007/s11894-010-0166-4
9
X.L. Bai, T.B. Liang, L.H. Wu, D.L. Li, L. Geng, W.L. Wang, Y. Shen, M. Zhang, S.S. Zheng. Elevation of Intact Parathyroid Hormone Level Is a Risk Factor for Low Bone Mineral Density in Pretransplant Patients With Liver DiseasesTransplantation Proceedings 2007; 39(10): 3182 doi: 10.1016/j.transproceed.2007.06.093
10
Ali Gur, Bünyamin Dikici, Kemal Nas, Mehmet Bosnak, Kenan Haspolat, Aysegul Jale Sarac. Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis?BMC Gastroenterology 2005; 5(1) doi: 10.1186/1471-230X-5-30
11
Todd T. Brown, Michael T. Yin. Osteoporosis2013; : 1305 doi: 10.1016/B978-0-12-415853-5.00054-6
12
Anindita Banerjee, Shreyasi Athalye, Naveen Khargekar, Poonam Shingade, Manisha Madkaikar. Chronic Hepatitis B and Related Liver Diseases Are Associated with Reduced 25-Hydroxy-Vitamin D Levels: A Systematic Review and Meta-AnalysisBiomedicines 2023; 11(1): 135 doi: 10.3390/biomedicines11010135
13
Núria Guañabens, Albert Parés. Liver and boneArchives of Biochemistry and Biophysics 2010; 503(1): 84 doi: 10.1016/j.abb.2010.05.030
14
Scott Fung, Peter Kwan, Milotka Fabri, Andrzej Horban, Mijomir Pelemis, Hie-Won Hann, Selim Gurel, Florin A. Caruntu, John F. Flaherty, Benedetta Massetto, Phillip Dinh, Amoreena Corsa, G. Mani Subramanian, John G. McHutchison, Petr Husa, Edward Gane. Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis BGastroenterology 2014; 146(4): 980 doi: 10.1053/j.gastro.2013.12.028
15
José M. Olmos-Martínez, José L. Hernández, Emilio Fábrega, José M. Olmos, Javier Crespo, Jesús González-Macías. Bone mineral density and trabecular bone score in treatment-naïve patients with non-cirrhotic hepatitis C virus infectionArchives of Osteoporosis 2020; 15(1) doi: 10.1007/s11657-020-00752-1
16
Panagiotis Kafas, Ilias Andreopoul, Georgios Kafas. Is the Success of Implant Surgery Influenced by Hepatitis B Condition? A Case ReportJournal of Medical Sciences 2007; 7(6): 1065 doi: 10.3923/jms.2007.1065.1067
17
Rahul Chaudhari, Sherouk Fouda, Ashik Sainu, Joseph M Pappachan. Metabolic complications of hepatitis C virus infectionWorld Journal of Gastroenterology 2021; 27(13): 1267-1282 doi: 10.3748/wjg.v27.i13.1267
18
Ming-Shyan Lin, Po-Han Chen, Po-Chang Wang, Huang-Shen Lin, Tung-Jung Huang, Shih-Tai Chang, Wen-Nan Chiu, Mei-Yen Chen. Association between hepatitis C virus infection and osteoporotic fracture risk among postmenopausal women: a cross-sectional investigation in TaiwanBMJ Open 2019; 9(1): e021990 doi: 10.1136/bmjopen-2018-021990
19
Stefano Mora, Vania Giacomet, Alessandra Viganò, Katia Maruca, Silvia Capelli, Pilar Nannini, Gian Vincenzo Zuccotti. Areal Bone Mineral Density in Pediatric Patients with Chronic Hepatitis B or Chronic Hepatitis CCalcified Tissue International 2014; 95(3): 218 doi: 10.1007/s00223-014-9884-1
20
Meital Gal-Tanamy, Larisa Bachmetov, Amiram Ravid, Ruth Koren, Arie Erman, Ran Tur-Kaspa, Romy Zemel. Vitamin D: An innate antiviral agent suppressing hepatitis C virus in human hepatocytesHepatology 2011; 54(5): 1570 doi: 10.1002/hep.24575
21
Astushi Nakamura, Tsubasa Yoshimura, Shunsuke Nagata, Manami Deguchi, Yuei Hosokawa, Go Someya, Takeshi Ichikawa, Keiji Okuyama, Yosihiro Yosioka, Hitoshi Asakura, Kenji Ogawa. Bone mass reductions in patients with chronic liver disease: the significance of bone mineral density measurements of vertebral bones using abdominal computed tomographyKanzo 2019; 60(11): 414 doi: 10.2957/kanzo.60.414
22
Leon Fisher, Alexander Fisher. Vitamin D and Parathyroid Hormone in Outpatients With Noncholestatic Chronic Liver DiseaseClinical Gastroenterology and Hepatology 2007; 5(4): 513 doi: 10.1016/j.cgh.2006.10.015
23
Liliana Montella, Raffaele Addeo, Giovannella Palmieri, Michele Caraglia, Gregorio Cennamo, Bruno Vincenzi, Rosario Guarrasi, Rosanna Mamone, Vincenzo Faiola, Nicola Frega, Elena Capasso, Luigi Maiorino, Davide Leopardo, Carmine Pizza, Vincenzo Montesarchio, Salvatore Del Prete. Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case seriesCancer Chemotherapy and Pharmacology 2010; 65(6): 1137 doi: 10.1007/s00280-009-1122-6
24
Ahmad Amanzada, Armin D. Goralczyk, Federico Moriconi, David H. van Thiel, Giuliano Ramadori, Sabine Mihm. Vitamin D status and serum ferritin concentration in chronic hepatitis C virus type 1 infectionJournal of Medical Virology 2013; 85(9): 1534 doi: 10.1002/jmv.23632
25
Connie Tien, Jason J. Xu, Linda S. Chan, Mimi Chang, Carolina Lim, Sue Lee, Brian Huh, Shuntaro Shinada, Ho S. Bae, Tse-Ling Fong. Long-Term Treatment with Tenofovir in Asian-American Chronic Hepatitis B Patients Is Associated with Abnormal Renal Phosphate HandlingDigestive Diseases and Sciences 2015; 60(2): 566 doi: 10.1007/s10620-014-3363-4
26
Alessandro Mantovani, Marco Dauriz, Davide Gatti, Ombretta Viapiana, Giacomo Zoppini, Giuseppe Lippi, Christopher D. Byrne, Fabrice Bonnet, Enzo Bonora, Giovanni Targher. Systematic review with meta‐analysis: non‐alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral densityAlimentary Pharmacology & Therapeutics 2019; 49(4): 375 doi: 10.1111/apt.15087
27
Eiichi Ogawa, Dae Won Jun, Hidenori Toyoda, Yao‐Chun Hsu, Eileen L. Yoon, Sang Bong Ahn, Ming‐Lun Yeh, Son Do, Huy N. Trinh, Hirokazu Takahashi, Masaru Enomoto, Norifumi Kawada, Satoshi Yasuda, Cheng‐Hao Tseng, Keigo Kawashima, Han Ah Lee, Kaori Inoue, Hiroaki Haga, Ai‐Thien Do, Mayumi Maeda, Joseph H. Hoang, Ramsey Cheung, Yoshiyuki Ueno, Yuichiro Eguchi, Norihiro Furusyo, Ming‐Lung Yu, Yasuhito Tanaka, Mindie H. Nguyen. Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational studyAlimentary Pharmacology & Therapeutics 2024; 59(2): 239 doi: 10.1111/apt.17785
28
Olga Katsarou, Evangelos Terpos, Pantelis Chatzismalis, Stefanos Provelengios, Theophanis Adraktas, Dimitrios Hadjidakis, Anna Kouramba, Anastasia Karafoulidou. Increased bone resorption is implicated in the pathogenesis of bone loss in hemophiliacs: correlations with hemophilic arthropathy and HIV infectionAnnals of Hematology 2010; 89(1): 67 doi: 10.1007/s00277-009-0759-x
29
Panagiotis V. Katsaounis, Emilia S. Hadjiyannis, Teressa Skaltsi, Vassiliki A. Anargyrou, Alexandra A. Alexopoulou, Spyridon P. Dourakis, John S. Koskinas. Bone disease in patients with cirrhosis of different etiology and severity; are Klotho protein and osteoprotegerin potential biomarkers?Scandinavian Journal of Gastroenterology 2023; 58(2): 185 doi: 10.1080/00365521.2022.2114813
30
Tugrul Purnak, Yavuz Beyazit, Ersan Ozaslan, Cumali Efe, Merve Hayretci. The evaluation of bone mineral density in patients with nonalcoholic fatty liver diseaseWiener klinische Wochenschrift 2012; 124(15-16): 526 doi: 10.1007/s00508-012-0211-4
31
P. Guggenbuhl, G. Chalès. Os et foieEMC - Hépatologie 2013; 8(2): 1 doi: 10.1016/S1155-1976(12)59777-9
32
Astrid E. Pulles, Simon C. Mastbergen, Roger E.G. Schutgens, Floris P.J.G. Lafeber, Lize F.D. van Vulpen. Pathophysiology of hemophilic arthropathy and potential targets for therapyPharmacological Research 2017; 115: 192 doi: 10.1016/j.phrs.2016.11.032
33
M. T. Yin, A. RoyChoudhury, K. Nishiyama, T. Lang, J. Shah, S. Olender, D. C. Ferris, C. Zeana, A. Sharma, B. Zingman, M. Bucovsky, I. Colon, E. Shane. Bone density and microarchitecture in hepatitis C and HIV-coinfected postmenopausal minority womenOsteoporosis International 2018; 29(4): 871 doi: 10.1007/s00198-017-4354-z
34
Andrija Jurina, Valentina Delimar, Zlatko Giljević, Tajana Filipec Kanižaj, Andro Matković, Dinko Vidović, Nikolina Jurjević, Vinko Vidjak, Željko Duić, Mario Ćuk, Mladen Japjec, Tomislav Dujmović, Andrea Radeljak, Mirjana Marjana Kardum Paro, Marijana Vučić-Lovrenčić, Mario Starešinić. Fragility spinal fractures among cirrhotic liver transplant candidates in CroatiaInjury 2024; 55(2): 111171 doi: 10.1016/j.injury.2023.111171
35
Jerzy Konstantynowicz, Dariusz M. Lebensztejn, Elzbieta Skiba, Maria E. Sobaniec-Lotowska, Pawel Abramowicz, Janina Piotrowska-Jastrzebska, Maciej Kaczmarski. Chronic non-cholestatic liver disease is not associated with an increased fracture rate in childrenJournal of Bone and Mineral Metabolism 2011; 29(3): 315 doi: 10.1007/s00774-010-0219-7
36
Christopher J. Danford, Hirsh D. Trivedi, Alan Bonder. Bone Health in Patients With Liver DiseasesJournal of Clinical Densitometry 2020; 23(2): 212 doi: 10.1016/j.jocd.2019.01.004
37
Jae Young Jang, Raymond T. Chung. New treatments for chronic hepatitis CThe Korean Journal of Hepatology 2010; 16(3): 263 doi: 10.3350/kjhep.2010.16.3.263
38
Myong Ki Baeg, Seung Kew Yoon, Sun-Hye Ko, Kyung-Do Han, Hye Jin Choi, Si Hyun Bae, Jong Young Choi, Myung-Gyu Choi. Males seropositive for hepatitis B surface antigen are at risk of lower bone mineral density: the 2008–2010 Korea National Health and Nutrition Examination SurveysHepatology International 2016; 10(3): 470 doi: 10.1007/s12072-015-9672-7
39
Wen-Hung Huang, Mei-Ching Yu, Jeng-Yi Huang, Ping-Chin Lai, Birke Bartosch. Impact of Hepatitis C Virus Infection on Bone Mineral Density in Renal Transplant RecipientsPLoS ONE 2013; 8(5): e63263 doi: 10.1371/journal.pone.0063263
40
Anirban Mukhopadhyay, Ujjwal Maulik, Wenzhe Ho. Network-Based Study Reveals Potential Infection Pathways of Hepatitis-C Leading to Various DiseasesPLoS ONE 2014; 9(4): e94029 doi: 10.1371/journal.pone.0094029
41
A. Mahmoudi, N. Sellier, J. Reboul-Marty, G. Chalès, Y. Lalatonne, V. Bourcier, V. Grando, N. Barget, M. Beaugrand, J.-C. Trinchet, N. Ganne-Carrié. Bone mineral density assessed by dual-energy X-ray absorptiometry in patients with viral or alcoholic compensated cirrhosis. A prospective studyClinics and Research in Hepatology and Gastroenterology 2011; 35(11): 731 doi: 10.1016/j.clinre.2011.07.009
42
Todd T. Brown, Michael T. Yin. Marcus and Feldman's Osteoporosis2021; : 1217 doi: 10.1016/B978-0-12-813073-5.00049-6
43
Anne Liu, An Le, Jian Zhang, Chris Wong, Clifford Wong, Linda Henry, Mindie H. Nguyen. Increasing co-morbidities in chronic hepatitis B patients: experience in primary care and referral practices during 2000–2015Clinical and Translational Gastroenterology 2018; 9(3): e141 doi: 10.1038/s41424-018-0007-6
44
Ann-Brit Eg Hansen, Lars Haukali Omland, Henrik Krarup, Niels Obel. Fracture risk in hepatitis C virus infected persons: Results from the DANVIR cohort studyJournal of Hepatology 2014; 61(1): 15 doi: 10.1016/j.jhep.2014.03.007
45
Tatiana Bering, Kiara G.D. Diniz, Marta Paula P. Coelho, Diego A. Vieira, Maria Marta S. Soares, Adriana M. Kakehasi, Maria Isabel T.D. Correia, Rosângela Teixeira, Dulciene M.M. Queiroz, Gifone A. Rocha, Luciana D. Silva. Association between pre‐sarcopenia, sarcopenia, and bone mineral density in patients with chronic hepatitis CJournal of Cachexia, Sarcopenia and Muscle 2018; 9(2): 255 doi: 10.1002/jcsm.12269
46
Mahmoud M. Sobh, Mohamed Abdalbary, Sherouk Elnagar, Eman Nagy, Nehal Elshabrawy, Mostafa Abdelsalam, Kamyar Asadipooya, Amr El-Husseini. Secondary Osteoporosis and Metabolic Bone DiseasesJournal of Clinical Medicine 2022; 11(9): 2382 doi: 10.3390/jcm11092382
47
Subhra Karmakar, Sangita Majumdar, Anasuya Maiti, Monalisa Choudhury, Aniruddha Ghosh, Asankur S. Das, Chandan Mitra. Protective Role of Black Tea Extract against Nonalcoholic Steatohepatitis-Induced Skeletal DysfunctionJournal of Osteoporosis 2011; 2011: 1 doi: 10.4061/2011/426863
48
Luciana G. S. Orsini, Marcelo M. Pinheiro, Charlles H. M. Castro, Antônio E. B. Silva, Vera L. Szejnfeld, Luc Malaval. Bone Mineral Density Measurements, Bone Markers and Serum Vitamin D Concentrations in Men with Chronic Non-Cirrhotic Untreated Hepatitis CPLoS ONE 2013; 8(11): e81652 doi: 10.1371/journal.pone.0081652
49
Kanjaksha Ghosh, Shrimati Shetty. Bone health in persons with haemophilia: a reviewEuropean Journal of Haematology 2012; 89(2): 95 doi: 10.1111/j.1600-0609.2012.01803.x
50
Aida Elleuch, Lassaad Chtourou, Khansa Chaabouni, Khalil Yaich, Manel Naifar, Hela Fourati, Ali Amouri, Sofien Baklouti, Nabil Tahri, Fatma Ayadi. Ostéodystrophie et marqueurs de remodelage osseux au cours des hépatopathies virales chroniques compenséesNutrition Clinique et Métabolisme 2020; 34(2): 149 doi: 10.1016/j.nupar.2019.10.002
51
Chien-Hua Chen, Cheng-Li Lin, Chia-Hung Kao. Association Between Chronic Hepatitis B Virus Infection and Risk of OsteoporosisMedicine 2015; 94(50): e2276 doi: 10.1097/MD.0000000000002276
52
Salvatore Petta, Donatella Ferraro, Calogero Cammà, Daniela Cabibi, Antonietta Di Cristina, Vito Di Marco, Rosa Di Stefano, Stefania Grimaudo, Alessandra Mazzola, Massimo Levrero, Concetta Scazzone, Antonio Craxì. Vitamin D Levels and Il28B Polymorphisms are Related to Rapid Virological Response to Standard of Care in Genotype 1 Chronic Hepatitis CAntiviral Therapy 2012; 17(5): 823 doi: 10.3851/IMP2100
53
Olivia McKenna, Catherine Blake. Management of hepatitis C: the potential benefits of exercisePhysical Therapy Reviews 2007; 12(4): 271 doi: 10.1179/108331907X223065
54
Diala El-Maouche, Shruti H. Mehta, Catherine Sutcliffe, Yvonne Higgins, Michael S. Torbenson, Richard D. Moore, David L. Thomas, Mark S. Sulkowski, Todd T. Brown. Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infectionJournal of Hepatology 2011; 55(4): 770 doi: 10.1016/j.jhep.2011.01.035
55
Agostino Gaudio, Piera Pennisi, Francesco Muratore, Gaetano Bertino, Annalisa Ardiri, Ivana Pulvirenti, Giovanni Tringali, Carmelo Erio Fiore. Reduction of volumetric bone mineral density in postmenopausal women with hepatitis C virus-correlated chronic liver disease: A peripheral quantitative computed tomography (pQCT) studyEuropean Journal of Internal Medicine 2012; 23(7): 656 doi: 10.1016/j.ejim.2012.05.011
56
Trevor A. Crowell, Kelly A. Gebo, Ashwin Balagopal, John A. Fleishman, Allison L. Agwu, Stephen A. Berry. Impact of Hepatitis Coinfection on Hospitalization Rates and Causes in a Multicenter Cohort of Persons Living With HIVJAIDS Journal of Acquired Immune Deficiency Syndromes 2014; 65(4): 429 doi: 10.1097/QAI.0000000000000059
57
Kavinderjit S. Nanda, Elizabeth J. Ryan, Barbara F. Murray, Jennifer J. Brady, Malachi J. McKenna, Niamh Nolan, Cliona O'Farrelly, John E. Hegarty. Effect of Chronic Hepatitis C Virus Infection on Bone Disease in Postmenopausal WomenClinical Gastroenterology and Hepatology 2009; 7(8): 894 doi: 10.1016/j.cgh.2009.01.011
58
T. A. WALLNY, D. T. SCHOLZ, J. OLDENBURG, C. NICOLAY, S. EZZIDDIN, P. H. PENNEKAMP, B. STOFFEL‐WAGNER, C. N. KRAFT. Osteoporosis in haemophilia – an underestimated comorbidity?Haemophilia 2007; 13(1): 79 doi: 10.1111/j.1365-2516.2006.01405.x
59
Michael T. Yin, Todd T. Brown. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism2018; : 474 doi: 10.1002/9781119266594.ch60
60
Ping Wang, Xue-Song Gao, Yao-Nan Zhang, Xue-Fei Duan. Progress in research of non-cirrhotic chronic viral hepatitis with osteoporosisWorld Chinese Journal of Digestology 2022; 30(11): 491 doi: 10.11569/wcjd.v30.i11.491
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
61
Juan Kong, Yang Ding, Cong Zhang, Yu Fu, Jie Du, Cheng Lu, Xiaoguang Dou, Yunzi Chen, Yan Chun Li, Qun Zhao. Severe Vitamin D-Deficiency and Increased Bone Turnover in Patients with Hepatitis B from Northeastern ChinaEndocrine Research 2013; 38(4): 215 doi: 10.3109/07435800.2013.768266
62
E. Cholongitas, E. Theocharidou, J. Goulis, E. Tsochatzis, E. Akriviadis, A. K. Burroughs. Review article: the extra‐skeletal effects of vitamin D in chronic hepatitis C infectionAlimentary Pharmacology & Therapeutics 2012; 35(6): 634 doi: 10.1111/j.1365-2036.2012.05000.x
63
Upkar S. Gill, Alexandra Zissimopoulos, Safa Al-Shamma, Katherine Burke, Mark J. W. McPhail, David A. Barr, Yiannis N. Kallis, Richard T. C. Marley, Paul Kooner, Graham R. Foster, Patrick T. F. Kennedy. Assessment of Bone Mineral Density in Tenofovir-Treated Patients With Chronic Hepatitis B: Can the Fracture Risk Assessment Tool Identify Those at Greatest Risk?Journal of Infectious Diseases 2015; 211(3): 374 doi: 10.1093/infdis/jiu471
64
Chisato Saeki, Mitsuru Saito, Akihito Tsubota. Association of chronic liver disease with bone diseases and muscle weaknessJournal of Bone and Mineral Metabolism 2024; 42(4): 399 doi: 10.1007/s00774-023-01488-x
65
Dana D. Byrne, Craig W. Newcomb, Dena M. Carbonari, Melissa S. Nezamzadeh, Kimberly B.F. Leidl, Maximilian Herlim, Yu-Xiao Yang, Sean Hennessy, Jay R. Kostman, Mary B. Leonard, A. Russell Localio, Vincent Lo Re. Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infectionJournal of Hepatology 2014; 61(2): 210 doi: 10.1016/j.jhep.2014.04.001
66
Michael T Yin, Qiuhu Shi, Donald R Hoover, Kathryn Anastos, Anjali Sharma, Mary Young, Alexandra Levine, Mardge H Cohen, Elizabeth Shane, Elizabeth T Golub, Phyllis C Tien. Fracture incidence in HIV-infected women: results from the Women's Interagency HIV StudyAIDS 2010; 24(17): 2679 doi: 10.1097/QAD.0b013e32833f6294
67
Anitha Yadav, Elizabeth J. Carey. Osteoporosis in Chronic Liver DiseaseNutrition in Clinical Practice 2013; 28(1): 52 doi: 10.1177/0884533612470145
68
M. Guarino, I. Loperto, S. Camera, V. Cossiga, C. Di Somma, A. Colao, N. Caporaso, F. Morisco. Osteoporosis across chronic liver diseaseOsteoporosis International 2016; 27(6): 1967 doi: 10.1007/s00198-016-3512-z
69
Arthur Belle, Emmanuel Gizard, Guillaume Conroy, Anthony Lopez, Magali Bouvier‐Alias, Stéphanie Rouanet, Laurent Peyrin‐Biroulet, Jean‐Michel Pawlotsky, Jean‐Pierre Bronowicki. 25‐OH vitamin D level has no impact on the efficacy of antiviral therapy in naïve genotype 1 HCV‐infected patientsUnited European Gastroenterology Journal 2017; 5(1): 69 doi: 10.1177/2050640616640157
70
Ahmed Megahed, Nanees Salem, Abeer Fathy, Tarik Barakat, Mona Abd El Latif Alsayed, Suzy Abd El Mabood, Khaled R. Zalata, Ahmed F. Abdalla. Pegylated interferon α/ribavirin therapy enhances bone mineral density in children with chronic genotype 4 HCV infectionWorld Journal of Pediatrics 2017; 13(4): 346 doi: 10.1007/s12519-017-0013-x
71
Chien-Hua Chen, Cheng-Li Lin, Chia-Hung Kao. Relation Between Hepatitis C Virus Exposure and Risk of OsteoporosisMedicine 2015; 94(47): e2086 doi: 10.1097/MD.0000000000002086
72
R. Pelazas González, E. González Reimers, R. Alemán Valls, E. García-Valdecasas, M.J. de La Vega Prieto, M.A. Gómez Rodríguez, J. López Prieto, F. Santolaria fernández. Osteopatía en el paciente afecto de infección por virus CRevista Española de Enfermedades Metabólicas Óseas 2009; 18(1): 15 doi: 10.1016/S1132-8460(09)70766-4
73
Michael T. Yin, Todd T. Brown. HIV and Bone Complications: Understudied Populations and New Management StrategiesCurrent HIV/AIDS Reports 2016; 13(6): 349 doi: 10.1007/s11904-016-0341-9
74
Yan Yang, Jing Zeng, Tingting Zhang, Jinjing Wang, Xiaojing Fan, Qiaomin Wang, Xuan Wang, Zhengrong Qi, Yi Fang. Association between resolved hepatitis B virus infection and femoral and spinal bone mineral density in American adults: a cross-sectional studyFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1237618
75
Inaam A. Nakchbandi, Schalk W. van der Merwe. Current understanding of osteoporosis associated with liver diseaseNature Reviews Gastroenterology & Hepatology 2009; 6(11): 660 doi: 10.1038/nrgastro.2009.166
76
Emilio González-Reimers, Javier López-Prieto, Ricardo Pelazas-González, M.Remedios Alemán-Valls, María José de la Vega-Prieto, Carlos Jorge-Ripper, M. Carmen Durán-Castellón, F Santolaria-Fernández. Serum Sclerostin in Hepatitis C Virus Infected PatientsJournal of Bone Metabolism 2014; 21(1): 69 doi: 10.11005/jbm.2014.21.1.69
77
Naim M Maalouf, Song Zhang, Henning Drechsler, Geri R Brown, Pablo Tebas, Roger Bedimo. Hepatitis C Co-infection and Severity of Liver Disease as Risk Factors for Osteoporotic Fractures Among HIV-Infected PatientsJournal of Bone and Mineral Research 2013; 28(12): 2577 doi: 10.1002/jbmr.1988
78
Gabriela Handzlik-Orlik, Michał Holecki, Krzysztof Wilczyński, Jan Duława. Osteoporosis in liver disease: pathogenesis and managementTherapeutic Advances in Endocrinology and Metabolism 2016; 7(3): 128 doi: 10.1177/2042018816641351
79
Nilüfer İrem Tunçer, Ayça Arman-Özçırpıcı, Bahar Füsun Oduncuoğlu, Alpdoğan Kantarcı. Osseous outgrowth on the buccal maxilla associated with piezosurgery-assisted en-masse retraction: A case seriesThe Korean Journal of Orthodontics 2018; 48(1): 57 doi: 10.4041/kjod.2018.48.1.57
80
Roger Bedimo, Minhee Kang, Pablo Tebas, Edgar T. Overton, Kimberly Hollabaugh, Grace McComsey, Debika Bhattacharya, Christopher Evans, Todd T. Brown, Babafemi Taiwo. Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected PatientsAIDS Research and Human Retroviruses 2016; 32(4): 325 doi: 10.1089/aid.2015.0204
81
Hae Jeong, Dong Kim. Bone Diseases in Patients with Chronic Liver DiseaseInternational Journal of Molecular Sciences 2019; 20(17): 4270 doi: 10.3390/ijms20174270
82
Rein Jan Piso, Madeleine Rothen, Jean Pierre Rothen, Matthias Stahl, Christoph Fux. Per oral substitution with 300000 IU vitamin D (Cholecalciferol) reduces bone turnover markers in HIV-infected patientsBMC Infectious Diseases 2013; 13(1) doi: 10.1186/1471-2334-13-577
83
E. Redondo-Cerezo, F. Casado-Caballero, J. L. Martin-Rodriguez, J. Hernandez-Quero, F. Escobar-Jimenez, J. L. Gonzalez-Calvin. Bone mineral density and bone turnover in non-cirrhotic patients with chronic hepatitis C and sustained virological response to antiviral therapy with peginterferon-alfa and ribavirinOsteoporosis International 2014; 25(6): 1709 doi: 10.1007/s00198-014-2663-z
84
Mahmoud Aboelneen Khattab. Targeting host factors: A novel rationale for the management of hepatitis C virusWorld Journal of Gastroenterology 2009; 15(28): 3472-3479 doi: 10.3748/wjg.15.3472
85
Ulrich Christian Bang, Thomas Benfield, Flemming Bendtsen, Lars Hyldstrup, Jens–Erik Beck Jensen. The Risk of Fractures Among Patients With Cirrhosis or Chronic PancreatitisClinical Gastroenterology and Hepatology 2014; 12(2): 320 doi: 10.1016/j.cgh.2013.04.031
86
Sylvie Lawson-Ayayi, Charles Cazanave, Alphonse Kpozehouen, Nicole Barthe, Nadia Mehsen, Mojgan Hessamfar, Michel Dupon, François Dabis, Didier Neau. Chronic Viral Hepatitis Is Associated With Low Bone Mineral Density in HIV-Infected Patients, ANRS CO 3 Aquitaine CohortJAIDS Journal of Acquired Immune Deficiency Syndromes 2013; 62(4): 430 doi: 10.1097/QAI.0b013e3182845d88
87
Hanaa H. Eldash, Zeze Th. Atwa, Mohammad A. Saad. Vitamin D deficiency and osteoporosis in hemophilic childrenBlood Coagulation & Fibrinolysis 2017; 28(1): 14 doi: 10.1097/MBC.0000000000000519
88
Roger J Bedimo, Beverley Adams-Huet, John Poindexter, Geri Brown, Irfan Farukhi, Rosinda Castanon, Diana Turner, Teresa Moore, Pablo Tebas, Naim M Maalouf. The Differential Effects of Human Immunodeficiency Virus and Hepatitis C Virus on Bone Microarchitecture and Fracture RiskClinical Infectious Diseases 2018; 66(9): 1442 doi: 10.1093/cid/cix1011
89
Andrea D Branch, Minhee Kang, Kimberly Hollabaugh, Christina M Wyatt, Raymond T Chung, Marshall J Glesby. In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir useThe American Journal of Clinical Nutrition 2013; 98(2): 423 doi: 10.3945/ajcn.112.048785
90
Yue-Si Zhong, Nan Lin, Mei-Hai Deng, Fu-Cheng Zhang, Zhao-Feng Tang, Rui-Yun Xu. Deficient Proliferation of Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Chronic Hepatitis B Viral Infections and Cirrhosis of the LiverDigestive Diseases and Sciences 2010; 55(2): 438 doi: 10.1007/s10620-009-0733-4
91
E. Carlos Rodríguez-Merchán, Víctor Jiménez-Yuste. Advances in Hemophilia Treatment2022; : 1 doi: 10.1007/978-3-030-93990-8_1
92
Pasquale Mansueto, Antonio Carroccio, Aurelio Seidita, Gaetana Di Fede, Antonio Craxì. Osteodystrophy in chronic liver diseasesInternal and Emergency Medicine 2013; 8(5): 377 doi: 10.1007/s11739-012-0753-5
93
Vijay Kumar, Amrita Chawla, Amandeep Kaur. Multiple Idiopathic Cervical Root Resorptions in Patients with Hepatitis B Virus InfectionJournal of Endodontics 2018; 44(10): 1575 doi: 10.1016/j.joen.2018.06.017
94
Núria Guañabens, Albert Parés. Osteoporosis in chronic liver diseaseLiver International 2018; 38(5): 776 doi: 10.1111/liv.13730
95
Wang-Sheng Ko, Fang-Ping Shen, Chia-Ju Shih, Ya-Ling Chiou. The 25(OH)Vitamin D Status Affected the Effectiveness of Oligo Fucoidan in Patients with Chronic Hepatitis B Virus Infection with Immune Tolerance PhaseNutrients 2020; 12(2): 321 doi: 10.3390/nu12020321
96
Christian Markus Lange, Jörg Bojunga, Elizabeth Ramos-Lopez, Michael von Wagner, Angela Hassler, Johannes Vermehren, Eva Herrmann, Klaus Badenhoop, Stefan Zeuzem, Christoph Sarrazin. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapyJournal of Hepatology 2011; 54(5): 887 doi: 10.1016/j.jhep.2010.08.036
97
W. P. Hofmann, B. Kronenberger, J. Bojunga, B. Stamm, E. Herrmann, A. Bücker, U. Mihm, M. Von Wagner, S. Zeuzem, C. Sarrazin. Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon α and ribavirin therapyJournal of Viral Hepatitis 2008; 15(11): 790 doi: 10.1111/j.1365-2893.2008.01038.x
98
Huan V. Dong, Yamnia I. Cortés, Stephanie Shiau, Michael T. Yin. Osteoporosis and fractures in HIV/hepatitis C virus coinfectionAIDS 2014; 28(14): 2119 doi: 10.1097/QAD.0000000000000363
99
Young Joo Yang, Dong Joon Kim. An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic SarcopeniaInternational Journal of Molecular Sciences 2021; 22(5): 2604 doi: 10.3390/ijms22052604
100
N. Lim, S. Jackson, C. Engler, J.R. Lake. The Impact of Tenofovir Disoproxil Fumarate on Reduced Bone Mineral Density and Fractures in Liver Transplant RecipientsTransplantation Proceedings 2021; 53(1): 215 doi: 10.1016/j.transproceed.2020.09.009
101
Ricardo Pelazas-González, Emilio González-Reimers, María Remedios Alemán-Valls, Francisco Santolaria-Fernández, Javier López-Prieto, Antonieta González-Díaz, Juan Luis Gómez-Sirvent, María José de la Vega-Prieto. Bone alterations in hepatitis C virus infected patientsEuropean Journal of Internal Medicine 2013; 24(1): 92 doi: 10.1016/j.ejim.2012.09.007
102
D. D. Byrne, C. W. Newcomb, D. M. Carbonari, M. S. Nezamzadeh, K. B. F. Leidl, M. Herlim, Y. X. Yang, S. Hennessy, J. R. Kostman, M. B. Leonard, A. R. Localio, V. Lo Re. Increased risk of hip fracture associated with dually treated HIV/hepatitis B virus coinfectionJournal of Viral Hepatitis 2015; 22(11): 936 doi: 10.1111/jvh.12398
103
S. Linari, G. Montorzi, D. Bartolozzi, M. Borderi, D. Melchiorre, M. Benelli, M. Morfini. Hypovitaminosis D and osteopenia/osteoporosis in a haemophilia population: a study in HCV/HIV or HCV infected patientsHaemophilia 2013; 19(1): 126 doi: 10.1111/j.1365-2516.2012.02899.x
104
M. KHAWAJI, K. ÅKESSON, E. BERNTORP. Long‐term prophylaxis in severe haemophilia seems to preserve bone mineral densityHaemophilia 2009; 15(1): 261 doi: 10.1111/j.1365-2516.2008.01912.x
105
Pál Miheller, Péter L. Lakatos, Miklós Tóth. Bone Homeostasis in Intestinal DisordersClinical Reviews in Bone and Mineral Metabolism 2010; 8(3): 140 doi: 10.1007/s12018-010-9069-z
106
Jung-Chun Lin, Tsai-Yuan Hsieh, Chia-Chun Wu, Peng-Jen Chen, Tung-Hung Chueh, Wei-Kuo Chang, Heng-Cheng Chu. Association Between Chronic Hepatitis C Virus Infection and Bone Mineral DensityCalcified Tissue International 2012; 91(6): 423 doi: 10.1007/s00223-012-9653-y
107
Grace Lai-Hung Wong, Henry Lik-Yuen Chan, Hoi-Yun Chan, Chi-Hang Tse, Angel Mei-Ling Chim, Angeline Oi-Shan Lo, Vincent Wai-Sun Wong. Adverse Effects of Vitamin D Deficiency on Outcomes of Patients With Chronic Hepatitis BClinical Gastroenterology and Hepatology 2015; 13(4): 783 doi: 10.1016/j.cgh.2014.09.050
108
Pascal Guggenbuhl, Gérard Chalès. Os et foieRevue du Rhumatisme Monographies 2013; 80(2): 88 doi: 10.1016/j.monrhu.2013.02.002
109
Roger Bedimo, James Cutrell, Song Zhang, Henning Drechsler, Ang Gao, Geri Brown, Irfan Farukhi, Rosinda Castanon, Pablo Tebas, Naim M. Maalouf. Mechanisms of bone disease in HIV and hepatitis C virusAIDS 2016; 30(4): 601 doi: 10.1097/QAD.0000000000000952
110
Serdar Sahin, Sevil Sadri, Zafer Baslar, Muhlis Cem Ar. Osteoporosis in Patients With Hemophilia: Single-Center Results From a Middle-Income CountryClinical and Applied Thrombosis/Hemostasis 2019; 25 doi: 10.1177/1076029619861689
111
C. L. Kempton, A. Antun, D. M. Antoniucci, W. Carpenter, M. Ribeiro, S. Stein, L. Slovensky, L. Elon. Bone density in haemophilia: a single institutional cross‐sectional studyHaemophilia 2014; 20(1): 121 doi: 10.1111/hae.12240
112
Roger Bedimo, Naim M. Maalouf, Vincent Lo Re. Hepatitis C virus coinfection as a risk factor for osteoporosis and fractureCurrent Opinion in HIV and AIDS 2016; 11(3): 285 doi: 10.1097/COH.0000000000000259